| Advances in the development of human protein microarrays JG Duarte, JM Blackburn Expert Review of Proteomics 14 (7), 627–641, 2017 | 88 | 2017 |
| Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette–Guérin followed by Ipilimumab in Patients … J Da Gama Duarte, S Parakh, MC Andrews, K Woods, A Pasam, C Tutuka, ... Frontiers in immunology 9, 411, 2018 | 60 | 2018 |
| γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells KF Chan, J Da Gama Duarte, S Ostrouska, A Behren Frontiers in Immunology 13, 2022 | 39 | 2022 |
| Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer‐testis antigens N Beeton‐Kempen, J Duarte, A Shoko, JM Serufuri, T John, J Cebon, ... International Journal of Cancer 135 (8), 1842-51, 2014 | 27 | 2014 |
| B cells and antibody production in melanoma J Da Gama Duarte, JM Peyper, JM Blackburn Mammalian Genome 29 (11), 790-805, 2018 | 24 | 2018 |
| PMA: Protein Microarray Analyser, a user-friendly tool for data processing and normalization J Da Gama Duarte, RW Goosen, PJ Lawry, JM Blackburn BMC Research Notes 11 (156), 2018 | 19 | 2018 |
| Protein function microarrays: design, use and bioinformatic analysis in cancer biomarker discovery and quantitation J Duarte, JM Serufuri, N Mulder, J Blackburn Bioinformatics of human proteomics, 39-74, 2013 | 19 | 2013 |
| Dual antiangiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II study J Mooi, F Chionh, P Savas, J Da Gama Duarte, G Chong, S Brown, ... Clinical Cancer Research 27 (8), 2159-2167, 2021 | 14 | 2021 |
| Immunoprofiling of breast cancer antigens using antibodies derived from local lymph nodes AR Young, JDG Duarte, R Coulson, M O’Brien, S Deb, A Lopata, ... Cancers 11 (5), 682, 2019 | 12 | 2019 |
| The good, the (not so) bad and the ugly of immune homeostasis in melanoma J Da Gama Duarte, K Woods, MC Andrews, A Behren Immunology & Cell Biology, 2018 | 12 | 2018 |
| Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial O Klein, D Kee, B Gao, B Markman, J da Gama Duarte, L Quigley, ... Journal for Immunotherapy of Cancer 9 (11), 2021 | 7 | 2021 |
| Protocol for investigating tertiary lymphoid structures in human and murine fixed tissue sections using Opal™-TSA multiplex immunohistochemistry LT Quigley, L Pang, E Tavancheh, M Ernst, A Behren, J Huynh, ... STAR protocols 4 (1), 101961, 2023 | 4 | 2023 |
| Ropporin-1 and 1b are widely expressed in human melanoma and evoke strong humoral immune responses J Da Gama Duarte, K Woods, LT Quigley, C Deceneux, C Tutuka, ... Cancers 13 (8), 1805, 2021 | 4 | 2021 |
| Identification of tumor antigens in ovarian cancers using local and circulating tumor-specific antibodies J Da Gama Duarte, LT Quigley, AR Young, M Hayashi, M Miyazawa, ... International journal of molecular sciences 22 (20), 11220, 2021 | 3 | 2021 |
| Proteomic studies on patient responses to chemotherapy, radiotherapy and immunotherapy in cancers JDG Duarte | 1 | 2015 |
| B Cells and Antibody Production in Cancer J Da Gama Duarte, E Tavancheh, LT Quigley, S Ostrouska, A Behren Handbook of Cancer and Immunology, 1-20, 2023 | | 2023 |
| A multispectral immunohistochemistry panel to investigate γδ T cells and butyrophilin molecules in the tumour microenvironment J Da Gama Duarte, LT Quigley, E Tavancheh, S Ostrouska, A Behren Exploration of Immunology, 383–392, 2022 | | 2022 |
| Ipilimumab and nivolumab in patients with rare gynaecological malignancies: Results of an Australian, multi-centre, phase 2 trial (CA209-538) D Kee, O Klein, B Gao, B Markman, J Da Gama Duarte, L Quigley, ... | | 2021 |
| Perfil lipídico em pacientes com acidente vascular agudo J Duarte | | 2009 |
